Literature DB >> 31255331

miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.

Li Li1, Yi-Ping Mou2, Yuan-Yu Wang3, Hui-Ju Wang1, Xiao-Zhou Mou1.   

Abstract

PURPOSE: To investigate the prognostic significance of miR-199a-3p and its role in invasion and metastasis in gastric cancer.
METHODS: miR-199a-3p expression in 436 formalin-fixed and 39 frozen gastric cancer tissues was investigated by in situ hybridization and RT-PCR, respectively. The role of miR-199a-3p in the migration and invasion of gastric cancer cells was determined in overexpression and inhibitor studies using transwell assays and the SGC-7901, BGC-823 and MGC-803 gastric cancer cells lines. The effect of miR-199a-3p expression on ethanolamine kinase 1 (ETNK1) levels was determined by western botting.
RESULTS: miR-199a-3p was significantly up-regulated in AGS, SGC-7901, BGC-823 and MGC-803 gastric cancer cells, when compared with GES-1 non-malignant gastric epithelial cells. In situ hybridization studies revealed that human non-tumor gastric mucosa samples were negative for miR-199a-3p expression, while 162 of 436 (37.16%) cases of gastric cancer demonstrated positive expression. miR-199a-3p overexpression was associated with tumor size, Lauren classification, depth of invasion, lymph node and distant metastasis, TNM stage and prognosis. In patients with I, II and III stage tumors, high miR-199a-3p expression was associated with a significantly lower 5-year survival rate. miR-199a-3p overexpression was associated with increased cell migration and invasion. ETNK1 expression was inhibited following miR-199a-3p overexpression in BGC-823 and SGC-7901 cells, and elevated following miR-199a-3p suppression in MGC-803 cells.
CONCLUSION: miR-199a-3p is highly expressed in gastric cancer, and correlates with invasion, metastasis and prognosis. miR-199a-3p regulates the invasion and migration of gastric cancer cells by targeting ETNK1. Consequently, miR-199a-3p may serve as a prognostic indicator in gastric cancer.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ETNK1; Gastric cancer; Invasion; Migration; Prognosis; miR-199a-3p

Mesh:

Substances:

Year:  2019        PMID: 31255331     DOI: 10.1016/j.prp.2019.152511

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.

Authors:  Zhenjie Fu; Yuqin Xu; Yan Chen; Hang Lv; Guiping Chen; Yitao Chen
Journal:  Biomed Res Int       Date:  2021-11-18       Impact factor: 3.411

2.  Novel cancer subtyping method based on patient-specific gene regulatory network.

Authors:  Mai Adachi Nakazawa; Yoshinori Tamada; Yoshihisa Tanaka; Marie Ikeguchi; Kako Higashihara; Yasushi Okuno
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

3.  miR-199a-3p plays an anti-tumorigenic role in lung adenocarcinoma by suppressing anterior gradient 2.

Authors:  Hui Liu; Yanfeng Wang; Yi Wang; Daoyuan Wu; He Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells.

Authors:  Guofeng Ma; Wen Xue; Jie Ni; Ran Tao
Journal:  J Oncol       Date:  2022-09-27       Impact factor: 4.501

5.  MicroRNA‑199a‑3p suppresses high glucose‑induced apoptosis and inflammation by regulating the IKKβ/NF‑κB signaling pathway in renal tubular epithelial cells.

Authors:  Ruimin Zhang; Linfang Qin; Jun Shi
Journal:  Int J Mol Med       Date:  2020-10-12       Impact factor: 4.101

6.  Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma.

Authors:  Zhongzhi Jin; Shengjun Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  RUNX3-mediated circDYRK1A inhibits glutamine metabolism in gastric cancer by up-regulating microRNA-889-3p-dependent FBXO4.

Authors:  Haofeng Liu; Qiu Xue; Hongzhou Cai; Xiaohui Jiang; Guangxin Cao; Tie Chen; Yuan Chen; Ding Wang
Journal:  J Transl Med       Date:  2022-03-10       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.